Goodazosin XL 5 Tablet contains prazosin hydrochloride 5 mg, an alpha-1 adrenergic receptor antagonist primarily indicated for the management of hypertension and symptoms of benign prostatic hyperplasia (BPH). By selectively blocking alpha-1 receptors on vascular smooth muscle, prazosin induces vasodilation, leading to a reduction in peripheral vascular resistance and blood pressure. This extended-release formulation ensures a sustained therapeutic effect, promoting better blood pressure control with once-daily dosing and improved patient compliance. Goodazosin XL 5 is also effective in alleviating lower urinary tract symptoms associated with BPH by relaxing smooth muscle in the bladder neck and prostate, thereby improving urinary flow and reducing obstruction. The medication should be initiated at a low dose to minimize the risk of orthostatic hypotension, with gradual titration based on clinical response and tolerability. Common adverse effects may include dizziness, headache, fatigue, and palpitations, typically transient and dose-related. Caution is advised in patients with a history of hypotension or those concurrently using other antihypertensive agents. Regular monitoring of blood pressure and symptom assessment is recommended to optimize therapeutic outcomes. Goodazosin XL 5 should be used under medical supervision, with adherence to prescribed dosing instructions to ensure safety and efficacy.